Helicobacter Infections clinical trials

The registry lists 53 studies for Helicobacter Infections across more than 10 countries. 9 are recruiting or about to start. 45 of them are mainly about Helicobacter Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Helicobacter Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 31
Status unknown: 7
Recruiting: 6
Terminated: 3
Not yet recruiting: 3
Withdrawn: 2

Phase

Phase 4: 15
Phase 3: 10
Phase 2: 6
Phase 1: 2

Where

Korea, Republic of: 8
United States: 7
China: 5
Taiwan: 4
Egypt: 3
Germany: 2

Who runs them

Seoul National University Bundang Hospital (5) · Il-Yang Pharm. Co., Ltd. (2) · Damascus Hospital (2) · National Taiwan University Hospital (2) · Shandong University (2) · MerLion Pharmaceuticals GmbH (2) · Hamamatsu University (2) · National Heart, Lung, and Blood Institute (NHLBI) (2)

What is being tested here

Drugs under test in Helicobacter Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Amoxicillin	1	2	8
Clarithromycin	1	2	6
Minocycline	1	1	1
Keverprazan	1	1	1
Vitamin D	1	0	1
Probiotic	1	0	1
Metronidazole	0	2	4
Rabeprazole	0	1	3
Lansoprazole	0	1	2
Esomeprazole	0	1	2

Drug classes tested here Proton pump inhibitors (PPIs) 8

Coming up

2phase 3 studies under way

4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Jun 2027Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication. · Phase 3 · Nanjing First Hospital, Nanjing Medical University
Dec 2026Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection · Tanta University
Apr 2027The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection · Seoul National University Bundang Hospital
Jun 2027Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori Eradication · Samsung Medical Center

Who these studies take

Of the 6 Helicobacter Infections studies recruiting now, 2 (33%) set no upper age limit and 2 (33%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (67%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	1 (17%)	1 (17%)
18	5 (83%)	5 (83%)
30	4 (67%)	4 (67%)
40	5 (83%)	5 (83%)
50	5 (83%)	5 (83%)
65	5 (83%)	5 (83%)
75	4 (67%)	4 (67%)
85	3 (50%)	3 (50%)

Across all 53 studies, recruiting or not: 43% stop at 75 or younger and 19% at 65; 23% take children; 0% are for women only and 6% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.Oct 29, 2026NCT07904429

Studies

Recruiting first, then most recently updated. Showing 50 of 53. Browse all 53 → or search them.